Lpl Financial LLC Tyra Biosciences, Inc. Transaction History

Lpl Financial LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$11.01 - $14.95 $44,040 - $59,800	-4,000 Reduced 27.59%	10,500 $145,000
Q3 2023 Nov 13, 2023	SELL	$13.15 - $16.08 $65,750 - $80,399	-5,000 Reduced 25.64%	14,500 $199,000
Q1 2023 May 10, 2023	SELL	$6.85 - $16.22 $3,425 - $8,109	-500 Reduced 2.5%	19,500 $313,000
Q3 2022 Nov 14, 2022	SELL	$6.61 - $12.42 $3,305 - $6,210	-500 Reduced 2.44%	20,000 $176,000
Q2 2022 Aug 12, 2022	BUY	$5.26 - $11.19 $107,830 - $229,395	20,500 New	20,500 $147,000

112

43.1M

3.8K

Ticker TYRA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,973,600
Market Cap $426M
Description
Tyra Biosciences, Inc., a preclinical-stage biopharmaceutical company, focuses on developing therapies to overcome tumor resistance and enhance outcomes for patients with cancer. Its lead product candidate is TYRA-300, a selective inhibitor of fibroblast growth factor receptor (FGFR)3 for the treatment of muscle invasive bladder cancer. The comp...

Get notified when there are updates to the investment portfolio of Lpl Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Lpl Financial LLC with notifications on news.